Oncology
🇺🇸 FDA Page 17FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global oncology market intelligence for pharma BD, investors, and analysts. Track drug approvals, clinical trials, and competitive landscapes.
Showing 193–204 of 246 articles
FDA Accelerated Approvals 2026: Zongertinib and Oncology Policy Shifts
UAE Cancer Clinical Trials: Middle East Oncology Hub Analysis 2024
Generic Oncology Drugs in Egypt: Market Analysis & Regional Impact
Clinical Trial Cost Analysis 2024: FDA Insights on Phase 1-3 Expenses
Medicare Coverage CAR-T Therapies: Policy Changes & Patient Impact 2024
FDA Accelerated Approvals Oncology: 2026 Policy Changes & Impact
Checkpoint Inhibitor Combinations Melanoma: Phase 3 Data & FDA Insights
FDA Approves Riabni Biosimilar: Expanding NHL Treatment Options
FDA Approval Adagrasib: Accelerated OK for KRAS G12C NSCLC Treatment
FDA Approves GenoPharm's Geno-Cure for Targeted Cancer Treatment
Whitehawk Therapeutics HWK-007 Shows Promise in AACR 2026 ADC Data Presentation
Salubris Biotherapeutics JK06 Shows Promise in Phase 1/2 Cancer Trial at AACR 2024